Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by canadapieton Jun 10, 2021 3:29pm
173 Views
Post# 33366588

RE:RE:RE:RE:RE:What a boring company....

RE:RE:RE:RE:RE:What a boring company....

canadapiet wrote:How on earth can someone with 100.000 shares get rid of them at a fair price ??????
Who wants to invest in a company with such an amazing volume every day????
Who wants to own shares of such a promising company?? if even the insiders "let the chalice pass by"???
Etc...


good luck 
SPCEO1 - (6/10/2021 12:38:03 PM) 
RE:RE:RE:RE:What a boring company....
I would not let the current low volume think you cannot trade the stock. I have owned it forever and owned it in size. Even when the stock was a $30 million market cap stock many years back, I was able to transact in it without too much difficulty. If you have stock to buy or sell, my experience is that you can do so without too much trouble and far less than recent trading volume would suggest.


Canadapiet:

Board:

What on earth would someone who wants normal transactions on the market to buy and sell be intrested in TH?????

94 M shares out and a daily minimal volume with no effect on shareprice eather way, up or down???? Never seen that before! 
The most obscure firms and also "normal" businesses have much more transactions and so intrest of several traders/investors! 
But hey, maybe one day we have our day like ORPH...........(not that i wish such casino"things").
Incomprehensible!!! 
(luckily, in the meantime, other cancer stocks  on Nasdaq are doing well....).

Ps: no answer from Mrs. L. Gibson yet.......

<< Previous
Bullboard Posts
Next >>